Bloomberg L.P.3d
Reckitt Surges Most in 24 Years After Baby Formula Trial Win
Shares of Reckitt Benckiser Group Plc jumped the most in 24 years following a US jury verdict that cleared it and Abbott ...
Reckitt (RKT) was downgraded to a Hold Rating at Bernstein
Bernstein analyst Callum Elliott downgraded Reckitt (RKT – Research Report) to a Hold today and set a price target of £53.00. The ...
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...
Reckitt Benckiser's Revenue Expected to Drop on Lower Sales Volumes -- Earnings Preview
SALES FORECAST: The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--is forecast to report a drop in quarterly revenue to 3.41 billion pounds ($4.43 billion) from 3.60 ...
Business Insider17h
Reckitt (RKT) Receives a Hold from Deutsche Bank
Deutsche Bank analyst Tom Sykes maintained a Hold rating on Reckitt (RKT – Research Report) today and set a price target of £50.00. The company’s shares opened today at p4,908.50. According to ...
Crain's Chicago Business4d
Abbott, Reckitt unit defeat claims in premature baby formula trial
The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
Business Recorder23h
FTSE 100 rebounds on Reckitt boost but logs weekly decline
LONDON: The UK’s FTSE 100 rebounded on Friday from near three-month lows touched in the prior session, as gains ...
RBC Capital Remains a Buy on Reckitt (RKT)
RBC Capital analyst James Edwardes Jones maintained a Buy rating on Reckitt (RKT – Research Report) today and set a price target of ...